S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Laser breakthrough could send stock soaring 2,467% (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Canadian autoworkers ratify new labor agreement with Ford
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Laser breakthrough could send stock soaring 2,467% (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Canadian autoworkers ratify new labor agreement with Ford
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Laser breakthrough could send stock soaring 2,467% (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Canadian autoworkers ratify new labor agreement with Ford
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Laser breakthrough could send stock soaring 2,467% (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Canadian autoworkers ratify new labor agreement with Ford
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
A coal mine fire in southern China's Guizhou province kills 16 people
NASDAQ:APDN

Applied DNA Sciences (APDN) Stock Forecast, Price & News

$1.26
-0.06 (-4.55%)
(As of 09/22/2023 ET)
Compare
Today's Range
$1.23
▼
$1.33
50-Day Range
$1.23
▼
$1.86
52-Week Range
$0.97
▼
$3.20
Volume
28,880 shs
Average Volume
36,993 shs
Market Capitalization
$17.21 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.50
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media

Applied DNA Sciences MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
177.8% Upside
$3.50 Price Target
Short Interest
Healthy
2.32% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.86) to ($0.68) Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.97 out of 5 stars

Industrial Products Sector

123rd out of 177 stocks

Miscellaneous Business Services Industry

4th out of 5 stocks

See Top Rated MarketRank™ Stocks Here

APDN stock logo

About Applied DNA Sciences (NASDAQ:APDN) Stock

Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. The company operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR)-based MDx testing services for the Monkeypox virus; and MDx test kits and related supplies, as well as validates pharmacogenetics (PGx) testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, leather, pharmaceuticals, nutraceuticals, and other products; SigNify IF portable DNA readers and SigNify consumable reagent test kits, which offers a front-line solution for supply chain integrity backed with forensic-level molecular tag authentication; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.

APDN Price History

APDN Stock News Headlines

September 18, 2023 | americanbankingnews.com
Applied DNA Sciences (NASDAQ:APDN) Now Covered by StockNews.com
September 17, 2023 | americanbankingnews.com
Applied DNA Sciences, Inc. (NASDAQ:APDN) Sees Large Drop in Short Interest
September 24, 2023 | Chaikin Analytics (Ad)
His system isolated NVIDIA - Here's His Next Buy.
Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.
September 14, 2023 | finance.yahoo.com
Applied DNA Partners with Cornell University College of Veterinary Medicine to Accelerate Development of Veterinary Vaccine Platform Targeting Diseases that Impact High-Value Animals
September 6, 2023 | finance.yahoo.com
Applied DNA Advances Commercialization of Linea(TM) IVT Platform, Appoints Beverly Wolgast as Executive Director of Quality and cGMP Programs
September 6, 2023 | finance.yahoo.com
Applied DNA Advances Commercialization of Linea(TM) IVT Platform, Appoints Beverly Wolgast as Executive Director of Quality and cGMP Programs
August 29, 2023 | finanznachrichten.de
Applied DNA Sciences, Inc.: Applied DNA Announces Availability and First Customer Shipment of New Linea IVT Evaluation Kit
August 29, 2023 | finance.yahoo.com
Applied DNA Announces Availability and First Customer Shipment of New Linea(TM) IVT Evaluation Kit
September 24, 2023 | Chaikin Analytics (Ad)
His system isolated NVIDIA - Here's His Next Buy.
Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.
August 24, 2023 | markets.businessinsider.com
Analysts Are Bullish on These Technology Stocks: Autodesk (ADSK), Applied DNA Sciences (APDN)
August 23, 2023 | finance.yahoo.com
Applied DNA Files Provisional Patent Applications for Methods of Double-Stranded RNA Mitigation in Next-Generation mRNA Production
August 11, 2023 | finanznachrichten.de
Applied DNA Sciences, Inc.: Applied DNA Reports Third Quarter Fiscal 2023 Financial Results and Provides Corporate Update
August 11, 2023 | finance.yahoo.com
Applied DNA Reports Third Quarter Fiscal 2023 Financial Results and Provides Corporate Update
August 9, 2023 | benzinga.com
Earnings Preview: Applied DNA Sciences
August 8, 2023 | finance.yahoo.com
ADT (ADT) Q2 Earnings and Revenues Miss Estimates
August 7, 2023 | finance.yahoo.com
Applied DNA to Report Third Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, August 10, 2023
August 4, 2023 | finance.yahoo.com
3 Penny Stocks to Buy Before the Breakout
July 18, 2023 | finanznachrichten.de
Applied DNA Sciences, Inc.: Applied DNA Biotherapeutics Subsidiary LineaRx to Participate in Upcoming mRNA Industry Conferences
July 14, 2023 | markets.businessinsider.com
Analysts Offer Insights on Technology Companies: Applied DNA Sciences (APDN) and Mogo Finance Technology (MOGO)
July 13, 2023 | finance.yahoo.com
Applied DNA Acquires RNA Polymerase Developer Spindle Biotech, Launches LineaIVT(TM) Platform to Substantially Improve mRNA Manufacturing and Broaden Market Reach
June 8, 2023 | finanznachrichten.de
Applied DNA Sciences, Inc.: Applied DNA Announces Presentation at Upcoming Healthcare Investor Conference
June 8, 2023 | finance.yahoo.com
Applied DNA Announces Presentation at Upcoming Healthcare Investor Conference
May 17, 2023 | markets.businessinsider.com
Analysts Offer Insights on Healthcare Companies: Star Equity Holdings (STRR), Applied DNA Sciences (APDN) and Dermata Therapeutics (DRMA)
May 16, 2023 | finance.yahoo.com
Applied DNA Sciences, Inc. (NASDAQ:APDN) Q2 2023 Earnings Call Transcript
May 11, 2023 | msn.com
Applied DNA Sciences: Q2 Earnings Insights
May 11, 2023 | finanznachrichten.de
Applied DNA Sciences, Inc.: Applied DNA Reports Second Quarter Fiscal 2023 Financial Results and Provides Corporate Update
May 11, 2023 | finance.yahoo.com
Applied DNA Reports Second Quarter Fiscal 2023 Financial Results and Provides Corporate Update
See More Headlines
Receive APDN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Applied DNA Sciences and its competitors with MarketBeat's FREE daily newsletter.

APDN Company Calendar

Last Earnings
8/10/2023
Today
9/24/2023
Fiscal Year End
9/30/2023
Next Earnings (Estimated)
12/13/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Miscellaneous business services
Sub-Industry
N/A
Sector
Industrial Products
Current Symbol
NASDAQ:APDN
CUSIP
N/A
CIK
744452
Web
www.adnas.com
Phone
(631) 240-8800
Fax
631-240-8900
Employees
61
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$3.50
High Stock Price Forecast
$4.00
Low Stock Price Forecast
$3.00
Forecasted Upside/Downside
+177.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-8,270,000.00
Net Margins
-43.47%
Pretax Margin
-43.79%
Return on Equity
-83.47%
Return on Assets
-42.24%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.23
Quick Ratio
4.14

Sales & Book Value

Annual Sales
$18.17 million
Price / Sales
0.95
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.08 per share
Price / Book
1.17

Miscellaneous

Outstanding Shares
13,660,000
Free Float
12,726,000
Market Cap
$17.21 million
Optionable
Optionable
Beta
0.59
A Guide To High-Short-Interest Stocks Cover
A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for October 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Dr. James A. Hayward Ph.D. (Age 69)
    Sc.D., Chairman, Pres & CEO
    Comp: $1.27M
  • Ms. Beth M. Jantzen CPA (Age 47)
    CPA, Chief Financial Officer
    Comp: $390k
  • Ms. Judith Murrah (Age 65)
    COO, Chief Information Officer & Sec.
    Comp: $438.75k
  • Mr. Sanjay M. Hurry
    Exec. Director of Investor Relations & Corp. Communications
  • Mr. Clay Shorrock Esq. (Age 38)
    J.D., Chief Legal Officer & Exec. Director of Bus. Devel.
  • Mr. Tony Benson
    Managing Director of EMEA
  • Mr. Joseph L. Magno
    Sales Consultant
  • Mr. Warren Pearlson
    Sales Consultant

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions













APDN Stock - Frequently Asked Questions

Should I buy or sell Applied DNA Sciences stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Applied DNA Sciences in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" APDN shares.
View APDN analyst ratings or view top-rated stocks.

What is Applied DNA Sciences' stock price forecast for 2023?

1 brokers have issued 1 year target prices for Applied DNA Sciences' stock. Their APDN share price forecasts range from $3.00 to $4.00. On average, they expect the company's stock price to reach $3.50 in the next twelve months. This suggests a possible upside of 177.8% from the stock's current price.
View analysts price targets for APDN or view top-rated stocks among Wall Street analysts.

How have APDN shares performed in 2023?

Applied DNA Sciences' stock was trading at $1.66 at the beginning of 2023. Since then, APDN shares have decreased by 24.1% and is now trading at $1.26.
View the best growth stocks for 2023 here.

Are investors shorting Applied DNA Sciences?

Applied DNA Sciences saw a decline in short interest in the month of August. As of August 31st, there was short interest totaling 316,800 shares, a decline of 19.0% from the August 15th total of 391,300 shares. Based on an average daily volume of 178,400 shares, the short-interest ratio is currently 1.8 days.
View Applied DNA Sciences' Short Interest.

When is Applied DNA Sciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, December 13th 2023.
View our APDN earnings forecast.

How were Applied DNA Sciences' earnings last quarter?

Applied DNA Sciences, Inc. (NASDAQ:APDN) issued its quarterly earnings data on Thursday, August, 10th. The technology company reported ($0.24) EPS for the quarter, meeting analysts' consensus estimates of ($0.24). The technology company had revenue of $2.92 million for the quarter, compared to the consensus estimate of $3.10 million. Applied DNA Sciences had a negative trailing twelve-month return on equity of 83.47% and a negative net margin of 43.47%. During the same quarter last year, the business posted ($0.33) EPS.

What is James A. Hayward's approval rating as Applied DNA Sciences' CEO?

2 employees have rated Applied DNA Sciences Chief Executive Officer James A. Hayward on Glassdoor.com. James A. Hayward has an approval rating of 100% among the company's employees. This puts James A. Hayward in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 100.0% of employees surveyed would recommend working at Applied DNA Sciences to a friend.

What other stocks do shareholders of Applied DNA Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Applied DNA Sciences investors own include Inovio Pharmaceuticals (INO), Advanced Micro Devices (AMD), Ekso Bionics (EKSO), Micron Technology (MU), Arbutus Biopharma (ABUS), VBI Vaccines (VBIV), Gilead Sciences (GILD), Vaxart (VXRT), Sorrento Therapeutics (SRNE) and Intel (INTC).

What is Applied DNA Sciences' stock symbol?

Applied DNA Sciences trades on the NASDAQ under the ticker symbol "APDN."

Who are Applied DNA Sciences' major shareholders?

Applied DNA Sciences' stock is owned by a number of institutional and retail investors. Top institutional shareholders include AMH Equity Ltd (2.58%), Citadel Advisors LLC (0.00%) and Simplex Trading LLC (0.00%).
View institutional ownership trends.

How do I buy shares of Applied DNA Sciences?

Shares of APDN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Applied DNA Sciences' stock price today?

One share of APDN stock can currently be purchased for approximately $1.26.

How much money does Applied DNA Sciences make?

Applied DNA Sciences (NASDAQ:APDN) has a market capitalization of $17.21 million and generates $18.17 million in revenue each year.

How can I contact Applied DNA Sciences?

Applied DNA Sciences' mailing address is 50 HEALTH SCIENCES DRIVE, STONY BROOK NY, 11790. The official website for the company is www.adnas.com. The technology company can be reached via phone at (631) 240-8800, via email at investor@adnas.com, or via fax at 631-240-8900.

This page (NASDAQ:APDN) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -